The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer

T-cell recruiting chemokines are required for a successful immune intervention in ovarian cancer, and also for the efficacy of modern anticancer agents such as PARP inhibitors. The chemokine CX3CL1 recruits tumour-suppressive T-cells into solid tumours, but also mediates cell–cell adhesions, e.g. of...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Stefanie Seitz, Tobias F. Dreyer, Christoph Stange, Katja Steiger, Dirk Wohlleber, Martina Anton, Thuý An Pham, Dominique Sauter-Peschke, Ute Reuning, Gabriele Multhoff, Wilko Weichert, Marion Kiechle, Viktor Magdolen, Holger Bronger
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-02-01
Serija:	Neoplasia: An International Journal for Oncology Research
Teme:	Chemokines CX3CL1 Tumour-infiltrating lymphocytes PARP inhibition Mouse model
Online dostop:	http://www.sciencedirect.com/science/article/pii/S1476558625000090
Oznake:	Označite Brez oznak, prvi označite!